GALACTOSE - NEONATAL SCREENING - ANVISA Registration 10298910171

Access comprehensive regulatory information for GALACTOSE - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10298910171 and manufactured by WALLAC OY. The registration is held by REVVITY DO BRASIL LTDA with validity until Jul 04, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including WALLAC OY, INTERNACIONAL CIENTÍFICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
2 Competitors
10298910171
2 Related Devices
Registration Details
ANVISA Registration Number: 10298910171
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

GSP® Neonatal Galactose Total kit - PN 3309-0020
Risk Class III

Registration Details

10298910171

25351252127202277

00351210000124

Company Information

WALLAC OY
Finland
PT: FINLÂNDIA

Dates and Status

Jul 04, 2022

04/07/2032

09/18/2025 19:00:01

GSP® Neonatal Galactose Total kit - PN 3309-0020
Risk Class III

Registration Details

10298910171

25351252127202277

00351210000124

Company Information

Dates and Status

Jul 04, 2022

04/07/2032

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "GALACTOSE - NEONATAL SCREENING"